Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 6/20 | 0.67 |
| ▸ | GABRB3 | P28472 | 6/20 | 0.67 |
| ▸ | GABRA5 | P31644 | 6/20 | 0.67 |
| ▸ | GABRA3 | P34903 | 6/20 | 0.67 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.67 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.58 |
| ▸ | MYC | P01106 | 1/20 | 0.55 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.53 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.51 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31273466 | 1.00 | GABRG2 (0.67) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL31273727 | 0.98 | GABRG2 (0.65) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL20395967 | 0.91 | MYC (0.57) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL23383673 | 0.88 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL22986972 | 0.88 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL22987006 | 0.88 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL23383839 | 0.88 | GABRG2 (0.55) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL23384027 | 0.88 | MYC (0.54) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL10431256 | 0.87 | GABRA1 (0.59) | GABRG2GABRB3GABRA5GABRA3GABRA1 | |
| SCHEMBL23383824 | 0.87 | GABRG2 (0.53) | GABRG2GABRB3GABRA5GABRA3GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2025-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | GABRG2 3351/4885GABRB3 2361/4885GABRA5 2984/4885 |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | GABRG2 3351/4885GABRB3 2361/4885GABRA5 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.